251 related articles for article (PubMed ID: 28807830)
1. USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein.
Li XY; Wu HY; Mao XF; Jiang LX; Wang YX
Biochem Biophys Res Commun; 2017 Oct; 492(1):48-54. PubMed ID: 28807830
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinase inhibitor degrasyn suppresses metastasis by targeting USP5-WT1-E-cadherin signalling pathway in pancreatic ductal adenocarcinoma.
Li J; Li H; Zhu W; Zhou B; Ying J; Wu J; Zhang H; Sun H; Gao S
J Cell Mol Med; 2020 Jan; 24(2):1370-1382. PubMed ID: 31845546
[TBL] [Abstract][Full Text] [Related]
3. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness.
Li Z; Jia Z; Gao Y; Xie D; Wei D; Cui J; Mishra L; Huang S; Zhang Y; Xie K
Clin Cancer Res; 2015 Feb; 21(4):844-53. PubMed ID: 25501129
[TBL] [Abstract][Full Text] [Related]
4. HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
Roca MS; Moccia T; Iannelli F; Testa C; Vitagliano C; Minopoli M; Camerlingo R; De Riso G; De Cecio R; Bruzzese F; Conte M; Altucci L; Di Gennaro E; Avallone A; Leone A; Budillon A
J Exp Clin Cancer Res; 2022 Mar; 41(1):83. PubMed ID: 35241126
[TBL] [Abstract][Full Text] [Related]
5. USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1.
Chen L; Xu Z; Li Q; Feng Q; Zheng C; Du Y; Yuan R; Peng X
Cell Death Dis; 2021 Sep; 12(10):887. PubMed ID: 34584067
[TBL] [Abstract][Full Text] [Related]
6. Mir-320b Inhibits Pancreatic Cancer Cell Proliferation by Targeting FOXM1.
Jingyang Z; Jinhui C; Lu X; Weizhong Y; Yunjiu L; Haihong W; Wuyuan Z
Curr Pharm Biotechnol; 2021; 22(8):1106-1113. PubMed ID: 32942974
[TBL] [Abstract][Full Text] [Related]
7. Glucose-Dependent FOXM1 Promotes Epithelial-to-Mesenchymal Transition Via Cellular Metabolism and Targeting Snail in Human Pancreatic Cancer.
Kyuno T; Kohno T; Konno T; Yamaguchi H; Kyuno D; Imamura M; Kimura Y; Kojima T; Takemasa I
Pancreas; 2020 Feb; 49(2):273-280. PubMed ID: 32011531
[TBL] [Abstract][Full Text] [Related]
8. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of SOX18 correlates with accelerated cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
Wang Y; Guo H; Zhang D; Yu X; Leng X; Li S; Zhu W
Biochem Biophys Res Commun; 2016 Oct; 479(3):510-516. PubMed ID: 27663663
[TBL] [Abstract][Full Text] [Related]
10. Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer.
Zhou Z; Chen H; Xie R; Wang H; Li S; Xu Q; Xu N; Cheng Q; Qian Y; Huang R; Shao Z; Xiang M
Mol Oncol; 2019 Apr; 13(4):873-893. PubMed ID: 30628173
[TBL] [Abstract][Full Text] [Related]
11. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
12. A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis.
Huang C; Qiu Z; Wang L; Peng Z; Jia Z; Logsdon CD; Le X; Wei D; Huang S; Xie K
Cancer Res; 2012 Feb; 72(3):655-65. PubMed ID: 22194465
[TBL] [Abstract][Full Text] [Related]
13. FOXM1-induced miR-552 expression contributes to pancreatic cancer progression by targeting multiple tumor suppressor genes.
Wang X; Dou N; Wang J; Zhang Y; Li Y; Gao Y
Int J Biol Sci; 2021; 17(4):915-925. PubMed ID: 33867818
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma.
Yu M; Tang Z; Meng F; Tai M; Zhang J; Wang R; Liu C; Wu Q
Tumour Biol; 2016 Jan; 37(1):1289-97. PubMed ID: 26289845
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin specific peptidase 5 promotes ovarian cancer cell proliferation through deubiquitinating HDAC2.
Du Y; Lin J; Zhang R; Yang W; Quan H; Zang L; Han Y; Li B; Sun H; Wu J
Aging (Albany NY); 2019 Nov; 11(21):9778-9793. PubMed ID: 31727867
[TBL] [Abstract][Full Text] [Related]
16. PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development.
Zhang Y; Ye X; Chen L; Wu Q; Gao Y; Li Y
Int J Biol Sci; 2018; 14(5):531-541. PubMed ID: 29805304
[TBL] [Abstract][Full Text] [Related]
17. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
Wierstra I
Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J
Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693
[TBL] [Abstract][Full Text] [Related]
19. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
[TBL] [Abstract][Full Text] [Related]
20. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
